Nietert P. J., Bradford W. D., Kaste L. M.. The impact of an innovative reform to the South Carolina dental medicaid system. Health Services Research 2005; 40 (4):1078-1091.
Nietert P. J., Bradford W. D., Kaste L. M.. The impact of an innovative reform to the South Carolina Dental Medicaid system. Health Services Research 2005; 40 (4):1078-91.
Nietert P. J., Mitchell H. C., Bolster M. B., Curran M. Y., Tilley B. C., Silver R. M.. Correlates of depression, including overall and gastrointestinal functional status, among patients with systemic sclerosis. Journal of Rheumatology 2005; 32 (1):51-57.
Nietert P. J., Mitchell H. C., Bolster M. B., Curran M. Y., Tilley B. C., Silver R. M.. Correlates of depression, including overall and gastrointestinal functional status, among patients with systemic sclerosis. Journal of Rheumatology 2005; 32 (1):51-7.
Nietert P. J., Shaftman S. R., Bolster M. B., Silver R. M.. Clinical and demographic predictors of in and out-of-hospital mortality among patients with systemic sclerosis. Arthritis and Rheumatism 2005; 52 (9):S172-S172.
Nietert P. J., Shaftman S. R., Bolster M. B., Silver R. M.. Predictors of long-term adverse outcomes among patients seen in an emergency room with systemic sclerosis. Arthritis and Rheumatism 2005; 52 (9):S671-S672.
Nietert P. J., Silver R. M., Mitchell H. C., Shafrman S. R., Tilley B. C.. Demographic and clinical factors associated with in-hospital death among patients with systemic sclerosis. Journal of Rheumatology 2005; 32 (10):1888-1892.
Nietert Paul J., Bradford W. David, Kaste Linda M.. The impact of an innovative reform to the South Carolina dental Medicaid system. Health Services Research 2005; 40 (4):1078-1091.
Nikrad M., Johnson T., Puthalalath H., Coultas L., Adams J., Kraft A. S.. The proteasome inhibitor bortezomib sensitizes cells to killing by death receptor ligand TRAIL via BH3-only proteins Bik and Bim. Molecular Cancer Therapeutics 2005; 4 (3):443-449.
Nikrad Malti, Johnson Thomas, Puthalalath Hamsa, Coultas Leigh, Adams Jerry, Kraft Andrew S.. The proteasome inhibitor bortezomib sensitizes cells to killing by death receptor ligand TRAIL via BH3-only proteins Bik and Bim. Molecular Cancer Therapeutics 2005; 4 (3):443-9.
Nishida M., Tanabe S., Maruyama Y., Mangmool S., Urayama K., Nagamatsu Y., Takagahara S., Turner J. H., Kozasa T., Kobayashi H., Sato Y., Kawanishi T., Inoue R., Nagao T., Kurose H.. G alpha(12/13)- and reactive oxygen species-dependent activation of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinase by angiotensin receptor stimulation in rat neonatal cardiomyocytes. Journal of Biological Chemistry 2005; 280 (18):18434-18441.
Njoku C. J., Gilkeson G. S., Patrick K. S., Oates J. C.. Effect of inducible nitric oxide synthase inhibitors on isoprostane production in murine lupus nephritis. Journal of Investigative Medicine 2005; 53 (1):S317-S317.
Njoku C. J., Patrick K. S., Ruiz P. Jr., Oates J. C.. Inducible nitric oxide synthase inhibitors reduce urinary markers of systemic oxidant stress in murine proliferative lupus nephritis. Journal of Investigative Medicine 2005; 53 (7):347-52.
Njoku C. J., Patrick K. S., Ruiz P., Oates J. C.. Inducible nitric oxide synthase inhibitors reduce urinary markers of systemic oxidant stress in murine proliferative lupus nephritis. Journal of Investigative Medicine 2005; 53 (7):347-352.
Noel P., Frueh B. C., Larme A. C., Pugh J. A.. Collaborative care needs and preferences of primary care patients with multimorbidity. Health Expectations 2005; 8 (1):54-63.
Noel P., Frueh B. C., Larme A. C., Pugh J. A.. Collaborative care needs and preferences of primary care patients with multimorbidity. Health Expectations 2005; 8 (1):54.
Noone T. C., Hosey J., Firat Z., Semelka R. C.. Imaging and localization of islet-cell tumours of the pancreas on CT and MRI. Best Practice and Research: Clinical Endocrinology and Metabolism 2005; 19 (2):195-211.
Noone Tara C., Hosey Jason, Firat Zeynep, Semelka Richard C.. Imaging and localization of islet-cell tumours of the pancreas on CT and MRI. Best Practice & Research Clinical Endocrinology & Metabolism 2005; 19 (2):195-211.
Norris J. S., Norris K. L., Holman D. H., El-Zawahry A., Keane T. E., Dong J. Y., Tavassoli M.. The present and future for gene and viral therapy of directly accessible prostate and squamous cell cancers of the head and neck. Future Oncology 2005; 1 (1):115-23.
Norris R. A., Kern C. B., Wessels A., Wirrig E. E., Markwald R. R., Mjaatvedt C. H.. Detection of beta ig-H3, a TGF beta induced gene, during cardiac development and its complementary pattern with periostin. Anatomy and Embryology 2005; 210 (1):13-23.
Norris R. A., Kern C. B., Wessels A., Wirrig E. E., Markwald R. R., Mjaatvedt C. H.. Detection of betaig-H3, a TGFbeta induced gene, during cardiac development and its complementary pattern with periostin. Anatomy and Embryology 2005; 210 (1):13-23.
Novgorodov S. A., Szulc Z. M., Luberto C., Jones J. A., Bielawski J., Bielawska A., Hannun Y. A., Obeid L. M.. Positively charged ceramide is a potent inducer of mitochondrial permeabilization. Journal of Biological Chemistry 2005; 280 (16):16096-16105.
Nunes S., Sa-Leao R., Carrico J., Alves C. R., Mato R., Avo A. B., Saldanha J., Almeida J. S., Sanches I. S., de Lencastre H.. Trends in drug resistance, serotypes, and molecular types of Streptococcus pneumoniae colonizing preschool-age children attending day care centers in Lisbon, Portugal: a summary of 4 years of annual surveillance. Journal of Clinical Microbiology 2005; 43 (3):1285-1293.
Nunes S., Sa-Leao R., Carrico J., Alves C. R., Mato R., Avo A. B., Saldanha J., Almeida J. S., Sanches I. S., de Lencastre H.. Trends in drug resistance, serotypes, and molecular types of Streptococcus pneumoniae colonizing preschool-age children attending day care centers in Lisbon, Portugal: a summary of 4 years of annual surveillance. Journal of Clinical Microbiology 2005; 43 (3):1285.
Nuyttens J. J., Harper J., Jenrette J. M., Turrisi A. T.. Outcome of radiation therapy for renal transplant rejection refractory to chemical immunosuppression. Radiotherapy and Oncology 2005; 74 (1):17-19.
Nuyttens J. J., Harper J, Jenrette J. M., Turrisi A. T. 3rd. Outcome of radiation therapy for renal transplant rejection refractory to chemical immunosuppression. [see comment]. Radiotherapy and Oncology 2005; 74 (1):17-9.
O'Neil P. M., Brown J. D.. Weighing the evidence: Benefits of regular weight monitoring for weight control. Journal of Nutrition Education and Behavior 2005; 37 (6):319-322.
O'Neil P. M., Brown J. D.. Weighing the evidence: benefits of regular weight monitoring for weight control. Journal of Nutrition Education and Behavior 2005; 37 (6):319-22.
O'Neil P. M., Brown J. D.. Weighing the evidence: benefits of regular weight monitoring for weight control. Journal of Nutrition Education and Behavior 2005; 37 (6):319-22.
O'Neil P. M., Rieder S.. Utility and validity of the Eating Behavior Inventory in clinical obesity research: a review of the literature. Obesity Reviews 2005; 6 (3):209-16.
O'Neil Patrick Mahlen, Brown Joshua D.. Weighing the evidence: Benefits of regular weight monitoring for weight control. Journal of Nutrition Education and Behavior 2005; 37 (6):319-322.
Oates J. C., Njoku C. J., Patrick K. S., Ruiz P., Gilkeson G. S.. Inducible nitric oxide synthase inhibitors reduce urinary markers of systemic oxidant stress in murine proliferative lupus nephritis. Arthritis and Rheumatism 2005; 52 (9):S627-S627.
Oates J. C., Varghese S., Bland A. M., Taylor T. P., Self S. E., Stanislaus R., Almeida J. S., Arthur J. M.. Prediction of urinary protein markers in lupus nephritis. Kidney International 2005; 68 (6):2588-2592.
Oates J. C., Varghese S., Bland A. M., Taylor T. P., Self S. E., Stanislaus R., Almeida J. S., Arthur J. M.. Prediction of urinary protein markers in lupus nephritis. Kidney International 2005; 68 (6):2588-92.
Ogilvie R. W.. Implementing virtual microscopy in medical education. FASEB JOURNAL 2005; 19 (4):A233-A233.
Ohnesorge B. M., Hofmann L. K., Flohr T. G., Schoepf U. J.. CT for imaging coronary artery disease: defining the paradigm for its application. INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING 2005; 21 (1):85-104.
Ohnesorge Bernd M., Hofmann Lars K., Flohr Thomas G., Schoepf U. Joseph. CT for imaging coronary artery disease: defining the paradigm for its application. The International Journal of Cardiovascular Imaging 2005; 21 (1):85-104.
Okonofua E. C., Cutler N. E., Lackland D. T., Egan B. M.. Ethnic differences in older americans: awareness, knowledge, and beliefs about hypertension. American Journal of Hypertension 2005; 18 (7):972-9.
Oldham J. M.. Guideline Watch: Practice Guideline for Treatment of Patients with Borderline Personality Disorder. Arlington, VA: American Psychiatric Association, Inc.; 2005.
Oldham J. M.. Treatment-treatment interactions. Journal of Psychiatric Practice 2005; 11 (1):1.
Oldham J. M.. Time, numbers and patient care. Journal of Psychiatric Practice 2005; 11 (2):71.
Oldham J. M.. Cultural competence. Journal of Psychiatric Practice 2005; 11 (4):217.
Oldham J. M.. The risk/benefit ratio of psychiatric treatment. Journal of Psychiatric Practice 2005; 11 (3):137.
Oldham J. M., Skodol A. E., Bender D. S.editors. Textbook of Personality Disorders. Arlington, VA: American Psychiatric Publishing, Inc., 2005.
Oldham John. From the editor: Disasters and perpetrators. Journal of Psychiatric Practice 2005; 11 (5):275.
Oldham John. From the editor: The risk of unintended consequences. Journal of Psychiatric Practice 2005; 11 (6):359.
Oldham John M.. Personality Disorders: Recent History and Future Directions. In: Oldham John M., Skodol Andrew E., Bender Donna S., editors. The American Psychiatric Publishing Textbook of Personality Disorders. Washington, DC: American Psychiatric Publishing, Inc, 2005. p. 3-16.
Oldham John M., Skodol Andrew E., Bender Donna S.editors. The American Psychiatric Publishing Textbook of Personality Disorders. Washington, DC: American Psychiatric Publishing, Inc, 2005.
Oleinik N. V., Krupenko N. I., Priest D. G., Krupenko S. A.. Cancer cells activate p53 in response to 10-formyltetrahydrofolate dehydrogenase expression. Biochemical Journal 2005; 391 ():503-511.
Oleinik N. V., Krupenko N. I., Priest D. G., Krupenko S. A.. Cancer cells activate p53 in response to 10-formyltetrahydrofolate dehydrogenase expression. Biochemical Journal 2005; 391 (Pt 3):503-11.
